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Introduction {#sec1}
============

During embryonic development, numerous cardiovascular cell types interact to build and maintain a functional heart. The epicardium is a mesothelial cell sheet that covers the heart's outer surface and, together with the myocardium and the endocardium, forms the wall of the heart (reviewed in [@bib72]). The epicardium derives from a transient extracardiac structure called the proepicardium (PEO) ([@bib45], [@bib56]), which emerges at around 55 h post fertilization (hpf) in the zebrafish embryo. Between 55 hpf and 72 hpf, proepicardial cells translocate to the ventricle via pericardial fluid movements, where they form a continuous cell layer ([@bib56]). Subsequently, a subset of epicardial cells undergoes an epithelial-to-mesenchymal transition, giving rise to epicardium-derived cells (EPDCs) ([@bib81]). These delaminating cells invade the subepicardial compartment and colonize the underlying myocardium to nurture the further growth of the developing heart muscle and coronary vessels by acting as an essential source of mitogens ([@bib58]).

In addition to providing signals, EPDCs can directly give rise to many of the cell types that form the developing heart. Studies have reported an epicardial contribution to adipose tissue ([@bib11], [@bib42], [@bib86]), vascular smooth muscle cells, necessary for vascular support and proper coronary formation, and cardiac fibroblasts in chick ([@bib19], [@bib44], [@bib49], [@bib59]), mouse ([@bib1], [@bib75], [@bib83], [@bib85], [@bib91]), and zebrafish ([@bib34]). A much less consensual view of EPDC fate exists concerning their putative differentiation into endothelial cells ([@bib19], [@bib48], [@bib57], [@bib60], [@bib90]) and cardiomyocytes ([@bib10], [@bib17], [@bib27], [@bib69], [@bib90]). These findings have relied heavily on tissue transplantation and Cre-based fate mapping analyses, which have limitations and may confound interpretation of results because of issues with activation of the Cre drivers in lineage derivatives and mosaic or ectopic expression of reporters ([@bib15]).

Although there has been significant progress understanding the biology of the epicardium, it is still not clear whether pre-migratory EPDCs are a homogeneous source of multipotent progenitors or become specified as epicardial subpopulations already within the epicardium proper. In the developing mouse and chick heart, the epicardial expression of *Tcf21*, *Wt1*, and *Tbx18* is restricted to subsets of cells ([@bib6]), establishing a precedent for cellular heterogeneity in the epicardium itself. This is supported by a recent study showing conserved heterogeneity within epicardium derived from human pluripotent stem cells ([@bib23]). Epicardial heterogeneity might be rooted in the fact that multiple tissues contribute to this structure. Although most zebrafish ventricular epicardial cells originate from the PEO, the epicardium covering the bulbus arteriosus (BA) was found to originate from the pericardial sac ([@bib55], [@bib61]). Additionally, the PEO itself was shown to be heterogeneous ([@bib64]). A subset of murine proepicardial cells that expresses the transcription factor Scleraxis (Scx) and the chemokine Semaphorin 3D (Sema3D) gives rise to the endocardium and coronary endothelium ([@bib31]). Most of these cells do not express Wt1 or Tbx18.

However, previous insights into epicardial heterogeneity have remained limited and restricted to a small number of epicardial markers. To gain unbiased insight into epicardial cell heterogeneity, we characterized the developmental transcriptome of the zebrafish epicardium at a single-cell level, combining confocal microscopy of newly generated epicardial reporter lines and single-cell transcriptomics. We identified and functionally characterized three transcriptionally distinct epicardial cell subpopulations, only one of which (Epi1) contained cells co-expressing the bona fide epicardial signature genes *tcf21*, *tbx18*, and *wt1b* ([@bib34], [@bib71]). Functional perturbation identified *tgm2b*, a transglutaminase gene highly enriched in Epi1, as necessary for the proper development of the epicardial cell sheet. The second subpopulation (Epi2), enriched in *tbx18* and smooth muscle markers such as *acta2* and *mylka*, was spatially localized outside the main epicardial layer, specifically in the smooth muscle of the BA. Loss of the chemokine semaphorin *3fb* (*sema3fb*), highly enriched in Epi2, increased the number of *tbx18*^*+*^ cells in the BA, revealing that *sema3fb* controlled the spatiotemporal access of epicardial cells to the outflow tract. The third subpopulation (Epi3) was highly enriched for cell guidance cues such as *cxcl12a*. Loss of this chemokine decreased the number of *ptprc/CD45*^+^ leukocytes on the epicardial surface, unraveling the importance of Epi3 in establishing intercellular communications responsible for the recruitment and/or retention of *ptprc/CD45*^+^ hematopoietic cells within the developing heart.

Building on the understanding of the genetic control of the developing epicardium, our study defines the molecular signatures and functional roles of specific epicardial cell subpopulations, thus providing insights into the specific programs within which the epicardium functions during cardiac development.

Results {#sec2}
=======

Expression of *tcf21*, *tbx18*, and *wt1b* Is Heterogeneous in the Developing Zebrafish Epicardium {#sec2.1}
--------------------------------------------------------------------------------------------------

Expression of *Tcf21, Tbx18*, and *Wt1* is restricted to subsets of epicardial cells in the developing mouse and chick heart ([@bib6]). Similar heterogeneity is present in the zebrafish epicardium ([@bib25], [@bib34]). However, the concurrent expression of all three epicardial genes has not been analyzed. Thus, we generated the zebrafish triple-reporter line *TgBAC(tcf21:myr-tdTomato;tbx18:myr-eGFP;wt1b:H2B-Dendra2)*^*ox187*^ ([Figures 1](#fig1){ref-type="fig"}A and 1B). Bacterial artificial chromosomes (BACs) contain large genomic fragments and recapitulate endogenous gene expression patterns more faithfully than promoter- or proximal enhancer-based transgenic lines ([@bib9]). In this line, membrane-tethered tdTomato and eGFP label *tcf21*^+^ and *tbx18*^+^ cells, respectively. Dendra2, localizing to the nucleus, identifies *wt1b*^+^ cells. The resulting combination of fluorescent signals enabled us to discriminate between epicardial cells that expressed combinations of *tcf21*, *tbx18*, and *wt1b* ([Figure 1](#fig1){ref-type="fig"}C). Whole-mount *in situ* hybridization chain reaction (HCR) ([@bib12], [@bib13]) validated the newly generated BAC reporter lines ([Figures 1](#fig1){ref-type="fig"}D--1F, 1D′--1F′, and 1F″). Confocal imaging of triple-reporter larvae at 3 days post fertilization (dpf) ([Figures 1](#fig1){ref-type="fig"}G and 1G′), 5 dpf ([Figures 1](#fig1){ref-type="fig"}H, 1H′, and [S1](#mmc1){ref-type="supplementary-material"}A--S1C), and 7 dpf ([Figures 1](#fig1){ref-type="fig"}I and 1I′) revealed that many epicardial cells did not express *tcf21*, *tbx18*, and *wt1b* simultaneously, but different subsets of the three markers ([Figures 1](#fig1){ref-type="fig"}G″--1I″ and 1G‴--1I‴). Interestingly, the distribution of these subsets differed across distinct morphological regions of the heart ([Figures 1](#fig1){ref-type="fig"}C and 1J--1L). For example, *wt1b*-only positive cells were mostly found on the BA, whereas *tcf21*/*tbx18*/*wt1b* triple-positive cells were mostly present on the ventricle. Furthermore, the relative number of triple-positive epicardial cells increased over time in all ventricular regions. However, in none of the cardiac regions did triple-positive cells become the only present epicardial subset. To validate these findings, we crossed the pre-existing reporter lines *TgBAC(tcf21:DsRed2)*^*pd37*^ and *TgBAC(tbx18:DsRed2)*^*pd22*^ ([@bib34]) to *Tg(wt1b:eGFP)*^*li1*^ ([@bib62]) and observed clear heterogeneity in the *tcf21*/*wt1b* and *tbx18*/*wt1b* double-fluorescent settings ([Figures S1](#mmc1){ref-type="supplementary-material"}D--S1K). We also observed epicardial heterogeneity at the endogenous gene expression level ([Figure S1](#mmc1){ref-type="supplementary-material"}L). At 5 dpf, we detected nuclei adjacent to *myl7*^+^ myocardium that featured endogenous *tcf21*, *tbx18*, and *wt1b* transcripts ([Figure 1](#fig1){ref-type="fig"}L″, asterisk). However, we also detected *tcf21*^*+*^ and *wt1b*^+^ areas that lacked *tbx18* expression ([Figure S1](#mmc1){ref-type="supplementary-material"}L‴, asterisk).Figure 1Heterogeneous Expression of *tcf21*, *tbx18*, and *wt1b* in the Developing Zebrafish Epicardium(A) Fluorescence of *tcf21*:myr-tdTomato (magenta membrane), *tbx18*:myr-eGFP (green membrane), and *wt1b*:H2B-Dendra2 (green nucleus).(B) Workflow to establish *TgBAC(tcf21:myr-tdTomato;tbx18:myr-eGFP;wt1b:H2B-Dendra2)*^*ox187*^. (C) Schematic of epicardial fluorescence patterns and cardiac regions analyzed. dsBA, distal bulbus arteriosus; prBA, proximal bulbus arteriosus; apV, arterial pole of the ventricle; and AVC, atrioventricular canal.(D--F) Single optical sections of mRNA stainings of (D) *tcf21* (cyan) and *tcf21*:myr-tdTomato (magenta), (E) *tbx18* (magenta) and *tbx18*:myr-eGFP (green), and (F) *wt1b* (magenta) and *wt1b*:H2B-Dendra2 (green). (D′--F′) Cell nuclei (asterisks) in the epicardial region surrounded by endogenous mRNA and fluorophore mRNA/protein.(G--I) Projections of the heart in triple reporter larvae at 3 dpf (G), 5 dpf (H), and 7 dpf (I).(G′ and H′) Single optical sections from (G) and (H).(I′) Short projection from (I).(G″--I″ and G‴--I‴) Representative epicardial fluorescence patterns.(J--L) Relative quantification of epicardial fluorescence patterns across the regions indicated in (C) at 3 dpf (J), 5 dpf (K), and 7 dpf (L).Scale bars: 20 μm in (D)--(F), 5 μm in (D′)--(F′), 50 μm in (G)--(I) and (G′)--(I′), and 10 μm in (G″)--(I″) and (G‴)--(I‴). Color channels were adjusted separately for brightness and contrast. Data in (J)--(L) are represented as mean minus standard deviation. Number of embryos analyzed: 3 dpf n = 6, 5 dpf n = 10, and 7 dpf n = 6. V, ventricle; BA, bulbus arteriosus.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Overall, both newly generated BAC transgenic reporter lines and co-expression of endogenous transcripts demonstrate that the expression of *tcf21*, *tbx18*, and *wt1b* in the developing zebrafish epicardium is heterogeneous.

Single-Cell Transcriptomic Profiling Identifies Distinct Cell Populations within the Developing Zebrafish Epicardium {#sec2.2}
--------------------------------------------------------------------------------------------------------------------

To further investigate the observed cellular heterogeneity, we performed single-cell RNA sequencing (scRNA-seq) using Smart-seq2 approach ([@bib63]) and a NextSeq500 platform (Illumina) to obtain 75-bp paired-end sequencing reads of the generated libraries (see [Figures S2](#mmc1){ref-type="supplementary-material"}A--S2F for quality control data). Because only a small fraction of cells in the heart is epicardial, we fluorescence-activated cell sorting (FACS)-purified cells from hearts extracted from *TgBAC(tcf21:H2B-Dendra2)*^*ox182*^, *TgBAC(tbx18:myr-eGFP)*^*ox184*^, and *TgBAC(wt1b:H2B-Dendra2)*^*ox186*^ transgenic embryos ([Figure 2](#fig2){ref-type="fig"}A; see [Figures S2](#mmc1){ref-type="supplementary-material"}G--S2K for FACS gating plots). To enhance cell clustering in our dataset, we also isolated cells from non-epicardial cardiac tissues such as myocardium (*Tg(myl7:eGFP)*^*f1*^) ([@bib29]), endocardium (*Tg(kdrl:GFP)*^*s843*^) ([@bib4]), and blood (*Tg(gata1a:DsRed)*) ([@bib78]), as well as cells from wild-type (WT) hearts. To enrich for *tcf21*^-^ epicardial cells, we purified non-fluorescent cells from *tcf21*:DsRed2; *myl7*:eGFP; *kdrl*:GFP; *gata1a*:DsRed quadruple transgenic reporter hearts. Following sequencing, we used the Pagoda pipeline ([@bib22]) and dimensionality reduction to uncover three distinct epicardial cell populations ([Figure 2](#fig2){ref-type="fig"}B). These populations, termed Epi1, Epi2, and Epi3, were predominantly formed by cells isolated from the epicardial reporter hearts, and cells within these subpopulations expressed *tcf21*, *tbx18*, and *wt1b* in a differential manner ([Figure 2](#fig2){ref-type="fig"}C). *tbx18* was mostly expressed in cells within Epi1 and Epi2 and *tcf21* within Epi1 and Epi3, whereas *wt1b* was confined to subsets of cells within Epi1 and, to a lesser extent, Epi3. We further identified five distinct non-epicardial cell clusters expressing known markers of other cardiac cell types, namely cardiomyocytes ([Figure 2](#fig2){ref-type="fig"}C, CMs; *vmhc* \[[@bib88]\]), erythroid hematopoietic cells ([Figure 2](#fig2){ref-type="fig"}C, eHCs; *gata1a* \[[@bib43]\]), myeloid or leukocyte hematopoietic cells ([Figure 2](#fig2){ref-type="fig"}C, mHCs; *lcp1* \[[@bib32]\]), neural cells ([Figure 2](#fig2){ref-type="fig"}C, NCs; *elavl3* \[[@bib54]\]) and mesenchymal cells ([Figure 2](#fig2){ref-type="fig"}C, MCs; *postna* \[[@bib73]\]). This classification was supported by the enrichment of additional genes ([Figure S3](#mmc1){ref-type="supplementary-material"}) and by the over-representation of gene ontology (GO) terms within the individual cell populations ([Figure 2](#fig2){ref-type="fig"}D). For example, cells in Epi1, Epi2, and Epi3 expressed many genes associated with epithelial cell fate commitment. Cells in Epi1 were enriched for genes associated with cell adhesion (Fisher's exact test; p = 1.3E−07) and epithelial migration (p = 6.1E−07), fitting the epicardial capacity to migrate as an epithelial cell sheet ([@bib82]). Cells in Epi2 expressed genes involved in vasoconstriction (p = 0.0227) and cell migration involved in heart development (p = 0.0021), suggesting they might fulfill a function outside the epicardial cell layer. Cells in Epi3 were enriched for genes associated with white blood cell migration (p = 0.0065) and axon extension (p = 0.0027), suggesting they might guide non-epicardial cells into the developing heart. To compare the reporter-based results described in [Figure 1](#fig1){ref-type="fig"} with the endogenous transcriptomic data, we quantified the expression of *tcf21*, *tbx18*, and *wt1b* in Epi1, Epi2, and Epi3 and found that only Epi1 contained cells that co-expressed all three markers ([Figure 2](#fig2){ref-type="fig"}E). Most cells in Epi2 exclusively expressed *tbx18*, and many cells in Epi3 exclusively expressed *tcf21*. Thus, the 5 dpf zebrafish heart contains three transcriptionally distinct epicardial cell populations that differentially express *tcf21*, *tbx18*, and *wt1b*.Figure 2Single-Cell RNA Sequencing Reveals Distinct Epicardial Cell Clusters in the Developing Zebrafish Heart(A) Overview of the scRNA-seq workflow.(B) t-distributed stochastic neighbor embedding (t-SNE) clustering of single-cell samples. Colors indicate the reporter or WT line cells were isolated from.(C) Identification of single-cell clusters based on marker gene expression. Three clusters labeled by *tcf21*, *tbx18*, and *wt1b* are designated Epi1-3. Color key indicates range of log~2~ transformed fragments per kilobase of transcript per million reads mapped (FPKM) expression values.(D) GO term over-representation in the clusters (columns). Bubble size depicts fold enrichment and color scale depicts the statistical significance, with p-values calculated using Fisher's exact test and Bonferroni correction for multiple hypothesis testing. GO terms important for further analysis are highlighted in red.(E) Relative quantification of the combinations of *tcf21*, *tbx18*, and *wt1b* expression in epi1--3 cells. CM, cardiomyocyte; eHC, erythroid hematopoietic cell; mHC, myeloid hematopoietic cell; NC, neural cell; and MC, mesenchymal cell.See also [Figures S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}.

Epi1, Epi2, and Epi3 Are Distinct in Their Transcriptomic Profile and Spatial Distribution within the Developing Heart {#sec2.3}
----------------------------------------------------------------------------------------------------------------------

Next, we interrogated the transcriptomic profiles of Epi1, Epi2, and Epi3. Single-cell gene enrichment analysis using scde ([@bib33]) showed that the retinoic acid synthesizing enzyme *retinaldehyde dehydrogenase* (*aldh1a2*), a known epicardial marker ([@bib34], [@bib39]), labeled Epi1 ([Figure 3](#fig3){ref-type="fig"}A). Epi1 cells also expressed genes without a previously ascribed epicardial function, such as the signaling peptide *adrenomedullin a* (*adma*), and the adhesion molecules *junctional adhesion molecule 2b* (*jam2b*) and *podocalyxin like* (*podxl*), suggesting that Epi1 might form the main epicardial cell sheet enveloping the heart. Using multiplexed hybridization chain reaction (HCR) *in situ* staining, we observed that both *adma* and *jam2b* mRNAs were present within the epicardial cell layer at 5 dpf, co-localizing with *tcf21* transcripts ([Figures 3](#fig3){ref-type="fig"}B--3B″).Figure 3Transcriptionally Distinct Epicardial Subpopulations Epi1--3 Localize to Different Regions of the Developing Heart(A) Marker gene expression in Epi1--3. Cells were clustered in an unsupervised manner (columns). Color key indicates range of log~2~ transformed FPKM values. Genes analyzed further are highlighted in red. CM, cardiomyocyte; eHC, erythroid hematopoietic cell; mHC, myeloid hematopoietic cell; NC, neural cell; and MC, mesenchymal cell.(B) mRNA staining of the Epi1 markers *adma* (magenta), *jam2b* (red), and *tcf21* (cyan) in a 5 dpf heart. (B′ and B″) A nucleus (asterisk) in the epicardial region surrounded by *adma*, *jam2b*, and *tcf21*.(C) mRNA staining of the Epi2 marker *elnb* (magenta) and *tbx18* (green) at 5 dpf. (C′ and C″) Overlap of *elnb* and *tbx18* in the BA.(D) Antibody staining of Mylka and *tbx18*:myr-Citrine at 5 dpf. (D′ and D″) Overlap of Mylka and myr-Citrine in the BA.(E) mRNA staining of the Epi3 marker *cldn11a* (magenta) and *tcf21* (cyan) at 5 dpf. (E′ and E″) Two nuclei (asterisks) in the epicardial region between BA and atrium in close proximity to *cldn11a* and *tcf21*. Scale bars: 20 μm in (B)--(E) and 5 μm in (B′)--(E′) and (B″)--(E″). Color channels were adjusted separately for brightness and contrast. (B)--(E) are single optical sections. V, ventricle; BA, bulbus arteriosus.

In addition to *tbx18*, Epi2 cells expressed smooth muscle cell markers such as *smooth muscle actin* (*acta2*) and *myosin light chain kinase* (*mylka*), as well as extracellular matrix components such as *lysyl oxidase a* (*loxa*) and *elastin b* (*elnb*) ([Figure 3](#fig3){ref-type="fig"}A). *elnb* was previously shown to be specifically expressed in the BA of the zebrafish heart ([@bib50]). Accordingly, we found the BA to be the only tissue in the 5 dpf zebrafish heart that expressed *elnb* mRNA ([Figures 3](#fig3){ref-type="fig"}C--3C″), as well as Mylka protein ([Figures 3](#fig3){ref-type="fig"}D--3D″). Furthermore, *tbx18* mRNA co-localized with *elnb* mRNA in the BA, and multiple Mylka^+^ cells were co-labeled by *tbx18*-driven myr-Citrine. These data reveal that Epi2 represents *tbx18*^*+*^ cells exclusively located in the smooth muscle layer of the BA.

RNA velocity analysis ([@bib38]) indicated that Epi2 cells might originate from cells resembling an Epi1 subpopulation ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Furthermore, pseudotime trajectories ([@bib77]) separated Epi1 from Epi2, but also revealed a subset of cells in Epi1 positioned proximally to Epi2 ([Figure S4](#mmc1){ref-type="supplementary-material"}B), suggesting that transcriptional transition from Epi1 to Epi2 could drive cellular transdifferentiation. To establish a lineage relationship between Epi2 and the epicardium beyond *tbx18* expression, we performed a tracing experiment using a *tcf21*-driven Cre *TgBAC(cryaa:EGFP,tcf21:Cre-ERT2)*^*pd42*^ ([@bib34]) crossed to the ubiquitous labeling line *Tg(ubi:Switch)* ([@bib51]). We incubated embryos with 4-hydroxytamoxifen (4-OHT) from either 10 hpf or 43 hpf, shortly before the PEO starts to form ([@bib56], [@bib71]). Similar to previous findings in the adult zebrafish BA ([@bib34]), we observed *tcf21-*derived cells in the smooth muscle layer of the larval BA, independently of when the 4-OHT treatment was started ([Figures S4](#mmc1){ref-type="supplementary-material"}C--S4E, p = 0.1614). This finding strongly supports an epicardial origin of Epi2 cells rather than an upregulation of *tbx18* mRNA in the BA. However, lineage tracing with a newly generated *TgBAC(wt1b:Cre-2A-mCherry)*^*ox142*^ line did not identify *wt1b*-derived cells in the BA ([Figures S4](#mmc1){ref-type="supplementary-material"}F and S4G), indicating that cells in Epi2 never express *wt1b*. Endogenous *wt1b* co-localized with *mCherry* transcripts ([Figure S4](#mmc1){ref-type="supplementary-material"}H), which, together with co-localization with the *TgBAC(wt1b:H2B-Dendra2)*^*ox186*^ reporter expression ([Figure S4](#mmc1){ref-type="supplementary-material"}I), validated the activity of the *TgBAC(wt1b:Cre-2A-mCherry)*^*ox142*^ line.

Cells in Epi3 expressed *claudin 11a* (*cldn11a*), coding for an essential tight junction component ([@bib26]) ([Figure 3](#fig3){ref-type="fig"}A). We observed co-localization of *cldn11a* and *tcf21* transcripts by HCR ([Figures 3](#fig3){ref-type="fig"}E--3E″), mostly in the epicardial region between the BA and the atrioventricular boundary. The spatial restriction of *cldn11a* expression was consistent with the small number of cells forming Epi3 ([Figure 2](#fig2){ref-type="fig"}C). Additionally, cells in Epi3 expressed the retinoic acid-responsive factors *nr1h5* and *rxraa*, known to interact in mammalian cells ([@bib53]), and the chemokine *cxcl12a* ([Figure 3](#fig3){ref-type="fig"}A). Therefore, Epi3 might be responsive to retinoic acid and involved in the guidance of non-epicardial cells.

The Epi1-Enriched Gene *Transglutaminase 2b* Is Essential for Maintaining the Integrity of the Epicardial Cell Layer {#sec2.4}
--------------------------------------------------------------------------------------------------------------------

To address whether epicardial heterogeneity underlies distinct cell fates and/or function, we used CRISPR-Cas9-mediated gene knockout. As single guide RNAs (sgRNAs) are rapidly degraded when not incorporated into Cas9 protein ([@bib7], [@bib28]), we used the Activator (Ac)-Dissociation (Ds) transposable element system ([@bib21], [@bib47]) to stably express sgRNAs ([@bib14]) in zebrafish. We first cloned sgRNAs targeting *Citrine* and *eGFP* into the Ac-Ds U6a mini-vector and injected reporter embryos with the corresponding sgRNA vector, Ac and Cas9 mRNAs. This led to widespread disruption of fluorescence ([Figure S5](#mmc1){ref-type="supplementary-material"}), indicating the system robustly and efficiently perturbed *Citrine* and e*GFP* expression using somatic CRISPR-Cas9 genome editing.

*Transglutaminase 2b* (*tgm2b*), a gene enriched in Epi1 ([Figure 4](#fig4){ref-type="fig"}A), codes for a protein-crosslinking enzyme previously studied during bone formation ([@bib16]). HCR analysis showed that *tgm2b* transcripts were broadly distributed within the epicardium and co-localized with *tcf21* and *tbx18* mRNAs ([Figures 4](#fig4){ref-type="fig"}B--4B″). We designed *tgm2b* sgRNAs targeting the region coding for the active site of glutamyltransferase activity ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B). Somatic knockout of *tgm2b* led to defects in the epicardial cell sheet at 5 dpf ([Figures 4](#fig4){ref-type="fig"}C and 4D). In severe cases, large regions of the epicardial cell layer were missing, and epicardial cell numbers were significantly reduced in *tgm2b* knockout larvae ([Figure 4](#fig4){ref-type="fig"}E, p = 0.0016 and 4F, p = 0.005). We further established two stable *tgm2b* mutant lines, *tgm2b*^*38ins/38ins*^ (mutant line 1, ox188, carrying 38-bp insertion in the *tgm2b* coding region) and *tgm2b*^*7del1sub/7del1sub*^ (mutant line 2, ox189, carrying 7-bp deletion and 1-bp substitution) ([Figure S6](#mmc1){ref-type="supplementary-material"}C). In both mutants, the resulting frameshift created an early translational termination site between WT residues 289 and 290 (length of WT tgm2b protein is 679 aa). *tgm2b* mutant larvae showed a reduction in epicardial cell numbers at 5 dpf, comparable with the phenotype observed in the transient *tgm2b* knockout ([Figure 4](#fig4){ref-type="fig"}E, p~*wt*~ ~versus\ homozyg~ = 0.0011 and 4F, p~wt~ ~versus\ homozyg~ = 0.0003). This phenotype might be due to a reduction in the number of epicardial cells that migrate from the PEO and attach to the myocardium, because the number of mutant *tcf21*^*+*^ epicardial cells was already lowered at 66 hpf ([Figures 4](#fig4){ref-type="fig"}G--4I, p~somatic~ ~KO~ = 0.0002, p~wt~ ~versus\ homozyg~ = 0.0051), yet the numbers in the PEO of control and mutant embryos were similar ([Figure 4](#fig4){ref-type="fig"}J, p~somatic~ ~KO~ = 0.5951, p~wt~ ~versus\ homozyg~ = 0.3964). We tested whether *tgm2b* might inhibit epicardial cell proliferation ([Figures 4](#fig4){ref-type="fig"}K--4N). Control and *tgm2b* transient knockout embryos were incubated with EdU from 66 hpf to 77 hpf and, surprisingly, we observed an increased number of proliferating *tcf21*^+^ cells in *tgm2b* knockout hearts. This suggests a compensatory mechanism for the decrease in epicardial cell numbers ([Figures 4](#fig4){ref-type="fig"}K--4M, p = 0.0062 and 4N, p = 0.0352).Figure 4*Transglutaminase 2b* Is Enriched in Epi1 and Functions to Maintain the Integrity of the Epicardial Cell Layer(A) Expression of *tgm2b*. Color key indicates range of log~2~ transformed FPKM values.(B) mRNA staining of *tgm2b* (magenta), *tcf21* (cyan), and *tbx18* (orange) in a 5 dpf heart. (B′ and B″) A nucleus (asterisk) in the epicardial region surrounded by *tgm2b*, *tcf21*, and *tbx18*.(C) The epicardium in a 5 dpf control larva.(D) Disrupted epicardial integrity in a 5 dpf KO *tgm2b* larva.(E) Absolute quantification of *tcf21*:H2B-Dendra2^+^ epicardial cell numbers at 5 dpf in transient *tgm2b* knockouts (Control, KO *tgm2b*) and stable *tgm2b* mutants (heterozygous, *tgm2b*^wt/mut^; homozygous, *tgm2b*^mut/mut^). Larvae from two mutant lines were analyzed.(F) Absolute quantification of *tbx18*:myr-Citrine^+^ epicardial cell numbers at 5 dpf.(G) The epicardium in a 66 hpf control embryo. White arrows indicate epicardial cells, and red arrowheads indicate cells in the PEO.(H) Reduced epicardial cell numbers in a 66 hpf KO *tgm2b* embryo.(I and J) Absolute quantification of *tcf21*:H2B-Dendra2^+^ epicardial (I) and proepicardial (J) cell numbers at 66 hpf.(K) Proliferation in the epicardium of a 77 hpf control larva (white arrows).(L) Increased epicardial proliferation in a KO *tgm2b* larva.(M) Relative quantification of proliferating epicardial cells.(N) Absolute quantification of *tcf21*:H2B-Dendra2^+^ epicardial cells. Scale bars: 50 μm in (C), (D), (G), and (H); 20 μm in (B); 10 μm in (K) and (L); and 5 μm in (B′) and (B″). Color channels were adjusted separately for brightness and contrast. (C), (D), (G), and (H) are projections; (B), (K), and (L) are single optical sections. Data are represented as median, first, and third quartiles (box). Significance was calculated using Welch's t test. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. V, ventricle; Ab, antibody.See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

In conclusion, *tgm2b* plays a critical role in maintaining the integrity of the forming epicardium and implicates Epi1 in ensuring the formation of a cohesive epithelial sheet of epicardial cells during heart development.

The Epi2-Enriched Gene *sema3fb* Regulates the Number of *tbx18*^+^ Cells that Contribute to the Smooth Muscle Layer of the Outflow Tract {#sec2.5}
-----------------------------------------------------------------------------------------------------------------------------------------

One of the most enriched factors in Epi2 was *sema3fb*, coding for a chemo-repellant known to be involved in neural patterning ([@bib76]) ([Figure 5](#fig5){ref-type="fig"}A). sema3fb belongs to the secreted class 3 semaphorins, which require a receptor complex consisting of a neuropilin (nrp1a/b or nrp2a/b) and a plexin for activity (reviewed in [@bib52]). We observed that *nrp1a* was co-expressed with *sema3fb* in Epi2, whereas most of the *nrp2a*^+^ cells were assigned to Epi1 that also featured *nrp1a* expression ([Figures 5](#fig5){ref-type="fig"}B and 5C). HCR analysis revealed that *sema3fb* was strongly expressed within the BA and only sparsely in the surrounding areas ([Figures 5](#fig5){ref-type="fig"}D and 5D′). In contrast, *nrp2a* mRNA was almost exclusively located in areas surrounding the BA ([Figure 5](#fig5){ref-type="fig"}D, arrowheads). *nrp1a* mRNA was present in close proximity to *sema3fb* in the BA ([Figure 5](#fig5){ref-type="fig"}D, arrows) and also adjacent to the BA. At the BA boundary, both *nrp1a* and *nrp2a* were detected in close proximity to *tbx18* ([Figure 5](#fig5){ref-type="fig"}D′, asterisk) and *tcf21* ([Figure 5](#fig5){ref-type="fig"}E, asterisk in 5E′). In summary, these results suggest that cells within the BA express *sema3fb* and *nrp1a* (and not *nrp2a*), whereas cells outside the BA, such as those within the adjacent epicardial layer, express *nrp2a* and *nrp1a* (and not *sema3fb*).Figure 5*Semaphorin 3fb* Is a Marker of Epi2 and Controls the Number of *tbx18*^+^ Cells in the Bulbus Arteriosus(A--C) Expression of *sema3fb* (A), *nrp1a* (B), and *nrp2a* (C). Color key indicates range of log~2~ transformed FPKM values.(D) mRNA staining of *sema3fb* (cyan), *nrp2a* (red, arrowheads), *nrp1a* (magenta, arrows), and *tbx18* (orange) at 5 dpf. (D′) Close proximity of *nrp2a*, *nrp1a,* and *tbx18* to a nucleus (asterisk) at the BA boundary.(E) mRNA staining of *nrp2a* (red), *nrp1a* (magenta), and *tcf21* (cyan) at 5 dpf. (E′) A nucleus (asterisk) in close proximity to *nrp2a*, *nrp1a*, and *tcf21*.(F) The BA in a 5 dpf control larva.(G) Increased numbers of *tbx18*:myr-Citrine^+^ cells (arrows) in the BA of a KO *sema3fb* larva.(H) Absolute quantification of *tbx18*:myr-Citrine^+^ cell numbers in the BA at 5 dpf.(I--N) Analysis of gene editing in single *sema3fb*-mutated epicardial cells. (I) t-SNE plot showing cell clusters and editing events. Numbers indicate cell identities, and colors depict editing events. Ld, large deletion; fs, frameshift; and sub, substitution. (J) Relative number of Cas9-edited *sema3fb*^+^ cells. Colors indicate the *sema3fb* sgRNA target site edited. (K) Frequency of editing event types. (L) Inferred edited sema3fb protein lengths, relative to WT. (M) Sashimi plots showing splicing of *sema3fb*. Arrows highlight reads splicing abnormally. Red bars indicate sgRNA target sites. (N) Relative number of *sema3fb* splicing reads that spliced abnormally.Scale bars: 10 μm in (D)--(G) and 5 μm in (D′) and (E′). Color channels were adjusted separately for brightness and contrast. (D)--(G) are single optical sections. Data in (H) and (L) are represented as median, first, and third quartiles (box). Significance calculated using Welch's t test. ^∗∗^p \< 0.01. V, ventricle; BA, bulbus arteriosus.See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

The expression pattern of *sema3fb* and the *nrp* receptors, together with the association of Epi2 to cardiac cell migration (Fisher's exact test; p = 0.00211) ([Figure 2](#fig2){ref-type="fig"}D), suggested that Epi2 could be a source of repulsive guidance cues for other epicardial cells migrating into the BA. To test this hypothesis, we performed somatic mutagenesis of *sema3fb* ([Figures S6](#mmc1){ref-type="supplementary-material"}D and S6E), which led to a significant increase in the number of *tbx18*^+^ cells in the BA ([Figures 5](#fig5){ref-type="fig"}F--5H, p = 0.0021), supporting a role for *sema3fb* in restricting the number of Epi2 cells in the outflow tract. We investigated whether this function might involve inhibition of *tbx18*^*+*^ cell proliferation in the BA ([Figures S6](#mmc1){ref-type="supplementary-material"}F and S6G, arrows). However, there was no significant difference in the number of proliferating *tbx18*^+^ cells, although many more *tbx18*:myr-Citrine^+^ cells were detected within the BA in *sema3fb* knockouts ([Figures S6](#mmc1){ref-type="supplementary-material"}F--S6H, p = 0.8202). This result argues against a role for *sema3fb* in restricting cell proliferation and suggests that it controls the number of *tbx18*^*+*^ cells in the BA, by restricting their migration from surrounding tissues such as the epicardium.

We further isolated cells from *tbx18*:myr-Citrine^+^*sema3fb* transient knockout hearts and performed scRNA-seq, adapting the recently established TARGET-seq method ([@bib68]). TARGET-seq allows the detection of mutations in both genomic DNA and transcriptome-derived cDNA at the single-cell level. We identified multiple types of *sema3fb*-gene-editing events in cells with sequencing read coverage of the *sema3fb* sgRNA target sites ([Figures 5](#fig5){ref-type="fig"}I--5K). Many of these ([Figure 5](#fig5){ref-type="fig"}I) were located in a cell cluster that was enriched in Epi2 markers ([Figures 3](#fig3){ref-type="fig"}A and [S6](#mmc1){ref-type="supplementary-material"}I). However, other cells analyzed for *sema3fb* gene editing formed part of an additional cluster termed "KOsema3fb" only present in the *sema3fb* knockout dataset ([Figure 5](#fig5){ref-type="fig"}I). The KOsema3fb cluster did not feature the widespread presence of Epi1 or Epi2 markers, although multiple cells in this cluster expressed *tbx18* and *Citrine* mRNA ([Figure S6](#mmc1){ref-type="supplementary-material"}I).

We found that 50% of the analyzed cells carried editing events, with both sgRNAs contributing to these ([Figure 5](#fig5){ref-type="fig"}J). Editing event types comprised insertions-deletions (indels) and nucleotide substitutions ([Figure 5](#fig5){ref-type="fig"}K). We analyzed *sema3fb* open reading frames (ORFs) after gene editing and found large deletions ([@bib35]) and indel-induced frameshifts ([Figure 5](#fig5){ref-type="fig"}L), which reduced sema3fb protein length in over a third of the samples analyzed ([Figure 5](#fig5){ref-type="fig"}I). In addition, in up to 20% of the sequenced transcripts, we found aberrant splicing of *sema3fb* cDNA ([Figures 5](#fig5){ref-type="fig"}M and 5N), such as splicing across multiple *sema3fb* exons ([Figure 5](#fig5){ref-type="fig"}M, cell 033, arrow) or abnormal splicing from a possible cryptic intronic site ([Figure 5](#fig5){ref-type="fig"}M, cell 052, arrow) ([Figure 5](#fig5){ref-type="fig"}N). Aberrant splicing of *sema3fb* was absent in the non-knockout scRNA-seq dataset ([Figure S6](#mmc1){ref-type="supplementary-material"}J), indicating that it was not an ordinarily occurring form of alternative splicing.

These results illustrate the impact of somatic *sema3fb* knockout on Epi2 cells and indicate that it reduces sema3fb functionality in around half of all *sema3fb*^+^ cells.

Epi3-Enriched *cxcl12a* Attracts Leukocytes to the Developing Heart {#sec2.6}
-------------------------------------------------------------------

Epi3 cells expressed the chemokine *cxcl12a* ([Figure 6](#fig6){ref-type="fig"}A). HCR revealed that the spatial distribution of *cxcl12a* transcripts was restricted to an area between BA and atrium ([Figures 6](#fig6){ref-type="fig"}B--6B″), very similar to *cldn11a* ([Figure 3](#fig3){ref-type="fig"}E), and a subset of *cxcl12a* was located in close proximity to *tcf21*, indicating co-expression.Figure 6The Chemokine *cxcl12a* Is Expressed in Epi3 and Attracts *ptprc*^+^ Leukocytes to the Epicardium(A) Expression of *cxcl12a*. Color key indicates range of log~2~ transformed FPKM values.(B) mRNA staining of *cxcl12a* (magenta) and *tcf21* (cyan) at 5 dpf. (B′ and B″) A nucleus (asterisk) in the epicardial region between BA and atrium surrounded by *cxcl12a* and *tcf21*.(C and D) Expression of *cxcr4b* (C) and *ptprc* (D). Color key indicates range of log~2~ transformed FPKM values.(E) mRNA staining of *cxcr4b* (green), *ptprc* (magenta), and *tcf21* (cyan) at 5 dpf. (E′) A nucleus (asterisk) in close proximity to *cxcr4b* and *ptprc*.(F) The heart in a 5 dpf control larva. (F′ and F″) *ptprc/Cd45*:DsRed^+^ cells in contact with the epicardium (arrows).(G and G′) Fewer *ptprc/CD45*:DsRed^+^ cells on the heart of a 5 dpf KO *cxcl12a* larva.(H) Absolute quantification of *ptprc/CD45*:DsRed^+^ cells in contact with the epicardium in transient *cxcl12a* knockouts (Control, KO *cxcl12a*) and stable *cxcl12a* mutants (heterozygous, *cxcl12a*^wt/mut^; homozygous, *cxcl12a*^mut/mut^).(I and J) RNA-seq analysis of *cxcl12a* gene editing in single control (ctr) and *cxcl12a*-knockout (KO) larvae. Relative numbers of edited reads that spanned the target site of *cxcl12a* sgRNA1 (I) or sgRNA3 (J).(K) Sashimi plots showing splicing of *cxcl12a*. Arrows highlight reads splicing from exon 1 into exon 3. Red bars indicate sgRNA target sites.(L) Relative number of reads splicing from *cxcl12a* exon 1 that spliced from exon 1 into exon 3.Scale bars: 50 μm in (F) and (G); 20 μm in (B); 10 μm in (F′), (F″), and (G′), and 5 μm in (B′), (B″), (E), and (E′). Color channels were adjusted separately for brightness and contrast. (F) and (G) are projections; (B), (E), (F′), (F″), and (G′) are single optical sections. Data in (H) and (L) are represented as median, first, and third quartiles (box). Significance calculated using Welch's t test. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. V, ventricle; eHC, erythroid hematopoietic cell; mHC, myeloid hematopoietic cell.See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

GO term analysis showed that Epi3 was enriched for genes involved in leukocyte chemotaxis (Fisher's exact test; p = 0.0067), a process also associated with the myeloid hematopoietic cell cluster (Fisher's exact test; p = 7.2E--06) ([Figure 2](#fig2){ref-type="fig"}D). Interestingly, the *cxcl12a* cognate receptor *cxcr4b* was strongly present in this population ([Figure 6](#fig6){ref-type="fig"}C, mHC), which was also enriched in *ptprc* (*CD45*) ([Figure 6](#fig6){ref-type="fig"}D), a pan-leukocyte marker in zebrafish ([@bib5]). HCR revealed areas on the ventricular surface in which *cxcr4b* and *ptprc/CD45* were co-localized ([Figures 6](#fig6){ref-type="fig"}E and 6E′, asterisk). *tcf21* was present in neighboring regions but was not closely co-localizing with *cxcr4b* or *ptprc/CD45*. This suggested that epicardial cxcl12a might be attracting *ptprc/CD45*^+^ leukocytes to the developing heart. We thus designed sgRNAs targeting the *cxcl12a* gene ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7B). Somatic loss of *cxcl12a* decreased the number of *ptprc/CD45*:DsRed^+^ cells ([@bib5]) that were present on the surface of the heart ([Figures 6](#fig6){ref-type="fig"}F--6H, p = 0.0003). We observed direct contact between *ptprc/CD45*:DsRed^+^ cells and the outer epicardial surface in controls (arrows in [Figures 6](#fig6){ref-type="fig"}F′ and 6F″) and reduced contacts in *cxcl12a* knockout larvae ([Figure 6](#fig6){ref-type="fig"}G′). We next established a stable mutant line featuring a 15-bp deletion at the start of the *cxcl12a* coding sequence, *cxcl12a*^*15del/15del*^ (ox190) ([Figure S7](#mmc1){ref-type="supplementary-material"}C). Homozygous mutant *cxcl12a*^*15del/15del*^ embryos showed a defect in lateral line development, recapitulating a previously published *cxcl12a* mutant phenotype arising from a different mutation ([@bib80]) ([Figures S7](#mmc1){ref-type="supplementary-material"}D--S7F). Importantly, the number of *ptprc/CD45*:DsRed^+^ cells in contact with the epicardium was significantly reduced in *cxcl12a* mutant larvae ([Figure 6](#fig6){ref-type="fig"}H, p~*wt*~ ~versus\ homozyg~ = 0.0042), consistent with our somatic *cxcl12a* knockout experiments. These data identify a role for *cxcl12a* in chemo-attracting leukocytes to the surface of the developing heart.

RNA-seq analysis of *cxcl12a* mRNA in single transient knockout larvae detected a variety of gene editing events ([Figures 6](#fig6){ref-type="fig"}I and 6J), with indels only detected in *cxcl12a* knockouts. Around 5% of the reads at the target site of *cxcl12a* sgRNA1 were edited ([Figure 6](#fig6){ref-type="fig"}I), whereas the editing frequency at the *cxcl12a* sgRNA3 target site was around 30% ([Figure 6](#fig6){ref-type="fig"}J). Furthermore, a significant number of reads spliced aberrantly from *cxcl12a* exon 1 into exon 3 in the *cxcl12a* transient knockouts ([Figures 6](#fig6){ref-type="fig"}J and 6K, arrows, and 6L). Additionally, we found that most indels should result in shortened *cxcl12a* ORFs ([Figures S7](#mmc1){ref-type="supplementary-material"}G and S7H), with aberrant splicing reducing the *cxcl12a* ORF to only 25% of its non-edited length ([Figure S7](#mmc1){ref-type="supplementary-material"}H). Despite the identified mutations, no significant reduction in *cxcl12a* mRNA levels was detected ([Figure S7](#mmc1){ref-type="supplementary-material"}I, p = 0.2221).

In summary, we found clear evidence of somatic *cxcl12a* gene editing. All *cxcl12a*-mutated larvae featured indels at both sgRNA target sites, as well as aberrant *cxcl12a* splicing, which likely affected cxcl12a protein size and function.

Discussion {#sec3}
==========

Understanding epicardial cell fate and lineage potential to date has been constrained by the limited set of so-called canonical markers which are either, not entirely specific for epicardial cells or, fail to label the entire epicardial cell pool. Here, we identify epicardial cell subpopulations within the developing zebrafish heart, characterize their transcriptional profiles at the single-cell level, and functionally test their involvement during heart development in zebrafish.

Our study provides insights into the heterogeneity and associated functional diversity of the developing epicardium. We identify the epicardial cell populations Epi1, Epi2, and Epi3, their distinct genetic programs and spatial distributions ([Figure 7](#fig7){ref-type="fig"}A). GO analysis of the most highly enriched genes in each of these clusters and perturbation of signature genes provided insights into the maintenance of epicardial integrity, formation of the outflow tract, and myeloid cell recruitment into the developing heart. Because of the relatively low cell numbers analyzed in our dataset, there might, however, be additional scarce epicardial subpopulations that remained undetected.Figure 7Summary of the Distinct Epicardial Cell Populations in the Developing Zebrafish Heart(A) Zebrafish heart at 5 dpf, showing the distributions of Epi1-3.(B) Loss of *tgm2b* disrupts the integrity of the epicardial cell layer.(C) Loss of *sema3fb* increases the number of Epi2 cells in the BA, possibly owing to increased cell migration from the epicardium.(D) Loss of *cxcl12a* decreases the number of myeloid cells on the heart. V, ventricle; BA, bulbus arteriosus.

Maintenance of Epithelial Integrity within the Forming Epicardium {#sec3.1}
-----------------------------------------------------------------

GO term analysis of Epi1 genes indicated a possible Epi1 role in the formation of a coherent epicardial cell sheet that migrates to envelope the myocardium. We focused on *tgm2b*, whose functional perturbation decreased epicardial cell numbers ([Figure 7](#fig7){ref-type="fig"}B). Interestingly, cell numbers in the PEO were unaffected by *tgm2b* knockout ([Figure 4](#fig4){ref-type="fig"}J), arguing against an early specification defect. Similarly, defective proliferation in the early epicardium was excluded as a possible cause for the reduction in epicardial cell numbers ([Figures 4](#fig4){ref-type="fig"}K--4M). Instead, there might be a reduction in the number of pro-epicardial cells that are able to attach to the myocardium during epicardium formation ([@bib37], [@bib70], [@bib87]), a process also known to require heartbeat-derived fluid flow ([@bib56]). Additionally, *tgm2b* might be involved in the regulation of cell-cell contacts within the epicardial cell layer.

The Regulation of Epicardial Cell Migration into the Outflow Tract {#sec3.2}
------------------------------------------------------------------

GO term analysis of Epi2-enriched genes suggested that this subpopulation might be linked to the smooth muscle wall of the BA. Indeed, many Epi2-specific genes were exclusively expressed in the developing smooth muscle layer of the BA. We show that these *tbx18*^+^ Epi2 cells had a *tcf21* origin but never expressed *wt1b*. Pseudotime analysis suggested that a subset of Epi1 cells might be in a transition state toward Epi2 ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B), supported by our *tcf21* lineage tracing results. The BA of the adult zebrafish heart is a positive regulator of epicardial cell migration ([@bib82]). Following cardiac injury, the BA is thought to drive the coordinated movement of the regenerating epicardial cell sheet via Sonic hedgehog signaling ([@bib82]). The secreted diffusible chemorepulsive factor sema3fb is enriched in Epi2 and functions to negatively regulate the number of epicardial cells that populate the BA ([Figure 7](#fig7){ref-type="fig"}C), therefore, acting as a gatekeeper controlling the number of cells in the outflow tract. Both sema3 signaling receptors, nrp1a and nrp2a, were expressed in the epicardium. NRP1 and NRP2 have been reported to interact with SEMA3 ligands differentially, with SEMA3F specifically binding to NRP2 and SEMA3A partnering with NRP1 (reviewed in [@bib52]). The fact that *nrp2a* transcripts were abundant in the vicinity of the BA, but excluded from the inside, supports a model in which nrp2a^+^ Epi1 cells are retained outside of the BA by the chemorepulsive activity of sema3fb, whereas nrp2a^−^ epicardial cells are able to migrate into and home to the BA. In transient *sema3fb* knockouts, we identified a *sema3fb*^+^, partially *tbx18*^+^ cell cluster not present in the WT setting ([Figures 3](#fig3){ref-type="fig"}A and [S6](#mmc1){ref-type="supplementary-material"}I), which may represent a population of cells that have abnormally homed to the BA. Our work highlights the importance of understanding the mechanisms enabling the migration of epicardial cells in response to diffusible guidance cues.

Epicardial Cell Regulation of Leukocyte Homing into the Heart {#sec3.3}
-------------------------------------------------------------

Epi3 might be involved in the guidance of white blood cells into the developing heart. Links between the epicardium and the immune system have been implicated during mouse fetal heart development, where CD68^+^ macrophages required the intact epicardium for their recruitment into the developing heart, a process dependent on the expression of *Wt1* ([@bib74]). Our study similarly reveals that the Epi3-enriched chemokine *cxcl12a* is necessary for the recruitment and/or retention of *ptprc/CD45*^+^ hematopoietic cells onto the surface of the heart ([Figure 7](#fig7){ref-type="fig"}D). These leukocyte or myeloid cells express the cognate chemokine receptor *cxcr4b*. Although there appear to be only a few Epi3 cells in the epicardium, their strong expression of the diffusible *cxcl12a* in the confined space of the pericardial cavity is likely to affect cxcl12a responsive cells in the vicinity, such as the *cxcr4b*^+^/*CD45*^+^ cells we analyzed. Thus, our work unravels a developmental mechanism by which an epicardial subpopulation regulates leukocyte recruitment through the expression of a paracrine signaling molecule. Non-PEO-derived CD45^+^ hematopoietic cells were shown to contribute to the developing epicardium of the mouse heart ([@bib3]). Therefore, it will be of interest to further explore the possible role of *cxcr4b*^+^/*CD45*^+^ cells present on the developing zebrafish heart. *Cxcl12a* is also expressed in adult epicardial cells upon cardiac injury ([@bib30]), and, in the mouse, epicardial-associated CD45^+^ hematopoietic cell clusters respond dynamically to myocardial infarction ([@bib3]). These cells co-express CD45^+^/*CXCR4*^+^/*CD11b*^+^ in the bone marrow and within the ischemic heart ([@bib24]), suggesting that *cxcl12a* may recapitulate its developmental role following adult heart injury.

In conclusion, our scRNA-seq work has opened up avenues for understanding epicardial cell biology and provides insights into the formation of a critical lineage, which is essential during both heart development and adult heart regeneration. The identification of functional subpopulations of epicardial cells and their roles as sources of chemo-attractant and repellent signals for cellular cross-talk during development may be exploited to facilitate cell-based therapies to regenerate the injured heart.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**chicken polyclonal anti-GFPabcamCat\# ab13970, RRID: [AB_300798](nif-antibody:AB_300798){#intref0010}Living Colors® DsRed Polyclonal Antibody rabbitClontechCat\# 632496,\
RRID: [AB_10013483](nif-antibody:AB_10013483){#intref0015}mouse monoclonal anti-Dendra2OrigeneCat\# TA180094, clone OTI1G6,\
RRID: [AB_2622288](nif-antibody:AB_2622288){#intref0020}mouse monoclonal anti-MlckSigma-AldrichCat\# M7905,\
RRID: [AB_477243](nif-antibody:AB_477243){#intref0025}rabbit polyclonal anti-cxcr4bGenetexCat\# GTX132244; RRID: [AB_2827420](nif-antibody:AB_2827420){#interref155}**Chemicals, Peptides, and Recombinant Proteins**RNase InhibitorClontechCat\# 2313ASMARTScribe reverse transcriptaseClontechCat\# 639537SeqAMP DNA polymeraseClontechCat\# 638509ProteaseQiagenCat\# 19155Herculase II Fusion DNA PolymeraseAgilentCat\# 600675**Critical Commercial Assays**Quant-iT PicoGreen dsDNA AssayThermo Fisher ScientificCat\# P11496Nextera XT library preparation kitIlluminaCat\# FC-131-1024RNAqueous Micro Total RNA isolation kitAmbionCat\# AM1931NextSeq ® 500/550 Mid Output Kit v2.5 (150 cycles)IlluminaCat\# 20024904NextSeq ® 500/550 High Output Kit v2.5 (75 cycles)IlluminaCat\# 20024906See [STAR Methods](#sec4){ref-type="sec"} section for Hybridization Chain Reaction (HCR) v3.0Molecular InstrumentsN/AClick-iT™ EdU Alexa Fluor™ 647 Imaging KitThermo Fisher ScientificCat\# C10340InFusion HD Cloning kitClontechCat\# 638910**Deposited Data**Raw and analysed single-cell RNA-seq dataThis paperGEO: [GSE121750](ncbi-geo:GSE121750){#intref0030}**Experimental Models: Organisms/Strains***TgBAC(tcf21:myr-tdTomato)*^*ox181*^Riley and Sauka-Spengler laboratoriesox181*TgBAC(tcf21:H2B-Dendra2)*^*ox182*^Riley and Sauka-Spengler laboratoriesox182*TgBAC(tcf21:myr-eGFP)*^*ox183*^Riley and Sauka-Spengler laboratoriesox183*TgBAC(tbx18:myr-eGFP)*^*ox184*^Riley and Sauka-Spengler laboratoriesox184*TgBAC(tbx18:myr-Citrine)*^*ox185*^Riley and Sauka-Spengler laboratoriesox185*TgBAC(wt1b:H2B-Dendra2)*^*ox186*^Riley and Sauka-Spengler laboratoriesox186*TgBAC(tcf21:myr-tdTomato;tbx18:myr-eGFP;wt1b:H2B-Dendra2)*^*ox187*^Riley and Sauka-Spengler laboratoriesox187*TgBAC(wt1b:Cre-2A-mCherry)*^*ox142*^Riley and Sauka-Spengler laboratoriesox142*Tg(tgm2b*^*38ins*^*;tcf21:H2B-Dendra2;tbx18:myr-Citrine)*^*ox188*^Riley and Sauka-Spengler laboratoriesox188*Tg(tgm2b*^*7del1sub*^*;tcf21:H2B-Dendra2;tbx18:myr-Citrine)*^*ox189*^Riley and Sauka-Spengler laboratoriesox189*Tg(cxcl12a*^*15del*^*; ptprc/CD45:DsRed; tcf21:myr-eGFP)*^*ox190*^Riley and Sauka-Spengler laboratoriesox190*TgBAC(tcf21:DsRed2)*^*pd37*^[@bib34]ZFIN: ZDB-TGCONSTRCT-110818-7*TgBAC(tbx18:DsRed2)*^*pd22*^[@bib34]ZFIN: ZDB-TGCONSTRCT-110818-6*TgBAC(cryaa:EGFP,tcf21:Cre-ERT2)*^*pd42*^[@bib34]ZFIN: ZDB-TGCONSTRCT-110818-8*Tg(wt1b:eGFP)*^*li1*^[@bib62]ZFIN: ZDB-TGCONSTRCT-071127-1*Tg(myl7:eGFP)*^*f1*^[@bib29]ZFIN: ZDB-TGCONSTRCT-070117-164*Tg(kdrl:GFP)*^*s843*^[@bib4]ZFIN: ZDB-TGCONSTRCT-070529-1*Tg(gata1a:DsRed)*[@bib78]ZFIN: ZDB-TGCONSTRCT-070117-38*Tg(ptprc/CD45:DsRed)*^*sd3*^[@bib5]ZFIN: ZDB-TGCONSTRCT-081120-3*Tg(--3.5ubb:loxP-EGFP-loxP-mCherry)*[@bib51]ZFIN: ZDB-TGCONSTRCT-110124-1*Tg(ubb:loxPAmCyanSTOPloxPZsYellow)*[@bib92]ZFIN: ZDB-TGCONSTRCT-111115-6**Oligonucleotides**Smart-seq2 LNA-TSO:\
AAGCAGTGGTATCAACGCAGAGTACATrGrG+G[@bib63]N/ASmart-seq2 OligodT-ISPCR primer:\
aagcagtggtatcaacgcagagtacttttttttttttttttttttttttttttttvn[@bib63]N/ASmart-seq2 ISPCR primer:\
AAGCAGTGGTATCAACGCAGAGT[@bib63]N/ASee [Table S1](#mmc1){ref-type="supplementary-material"} for BAC recombineering primersThis paperN/ASee [Table S2](#mmc1){ref-type="supplementary-material"} for sgRNA cloning primersThis paperN/ASee [Table S3](#mmc1){ref-type="supplementary-material"} for sgRNA/Cas9 nuclease activity test primersThis paperN/ASee [Table S4](#mmc1){ref-type="supplementary-material"} for *sema3fb* and *cxcl12a* cDNA/ genomic DNA primersThis paperN/A**Recombinant DNA**pGEM-BirA-2A-H2B-Dendra2-SV40pA-FKFThis paperAddgene Cat\# 119864pGEM-myr-Citrine-SV40pA-FKFThis paperAddgene Cat\#119865pGEM-myr-eGFP-SV40pA-FKFThis paperAddgene Cat\#119866pGEM-myr-tdTomato-SV40pA-FKFThis paperAddgene Cat\#119867pGEM-NLS-Cre-2A-mCherry-FKFThis paperAddgene Cat\#119868BAC clone DKEYP-79F12<https://www.sourcebioscience.com>DKEYP-79F12BAC clone DKEYP-117G5<https://www.sourcebioscience.com>DKEYP-117G5BAC clone CH73-157N22<https://www.sourcebioscience.com>CH73-157N22**Software and Algorithms**STAR v2.4.2a[@bib20]<https://github.com/alexdobin/STAR>samtools v1.3([@bib40])<http://htslib.org/>FeatureCounts v1.6.2[@bib41]<http://bioinf.wehi.edu.au/featureCounts>velocyto v0.17.13[@bib38]<http://velocyto.org/>R v3.4.3R Core Team<https://www.r-project.org/>scater v1.6.3[@bib46]<https://bioconductor.org/packages/release/bioc/html/scater.html>scde v1.99.4[@bib22]<http://hms-dbmi.github.io/scde/index.html>edgeR v3.20.9[@bib67]<https://bioconductor.org/packages/release/bioc/html/edgeR.html>velocyto.R v0.5[@bib38]<https://github.com/velocyto-team/velocyto.R>monocle v2.6.3[@bib65]<https://github.com/cole-trapnell-lab/monocle-release>topGO v2.30.1([@bib2])<http://bioconductor.org/packages/release/bioc/html/topGO.html>Rtsne v0.13[@bib36]<https://github.com/jkrijthe/Rtsne>ggplot2 v 2.2.1([@bib84])<https://ggplot2.tidyverse.org/>IGV v2.5.0([@bib66])<https://software.broadinstitute.org/software/igv/>

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Paul Riley (<paul.riley@dpag.ox.ac.uk>). Requests for zebrafish transgenic lines should be directed to Tatjana Sauka-Spengler (<tatjana.sauka-spengler@imm.ox.ac.uk>). All plasmids generated in this study are readily available from Addgene ([www.addgene.org/Tatjana_Sauka-Spengler/](http://www.addgene.org/Tatjana_Sauka-Spengler/){#intref0130} pGEM-BirA-2A-H2B-Dendra2-SV40pA-FKF, Cat\#119864; pGEM-myr-Citrine-SV40pA-FKF, Cat\#119865; pGEM-myr-eGFP-SV40pA-FKF, Cat\#119866; pGEM-myr-tdTomato-SV40pA-FKF Cat\#119867; pGEM-NLS-Cre-2A-mCherry-FKF, Cat\#119868).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

For this study, both females and males of transgenic and wildtype zebrafish strains were used. Animals used for breeding were between 3 and 24 months old. Zebrafish embryos/larvae that were used for experiments were raised to an age of up to 7 days post fertilisation (dpf). Larvae were euthanised and analysed shortly before reaching an age of 5dpf (free-feeding) during all experiments for which the experimental timepoint is stated as "5dpf" or "120hpf" in text or figures. Fish were kept at a 14 hours light, 10 hours dark cycle and fed four times a day. All animal experiments were performed under a Home Office Licence according to the Animals Scientific Procedures Act 1986, UK, and approved by the local ethics committee.

### Zebrafish Lines {#sec4.3.1}

Published transgenic reporter lines used in this study were: *TgBAC(tcf21:DsRed2)*^*pd37*^ ([@bib34]), *TgBAC(tbx18:DsRed2)*^*pd22*^ ([@bib34]), *TgBAC(cryaa:EGFP,tcf21:Cre-ERT2)*^*pd42*^ ([@bib34]), *Tg(wt1b:eGFP)*^*li1*^ ([@bib62]), *Tg(myl7:eGFP)*^*f1*^ ([@bib29]), *Tg(kdrl:GFP)*^*s843*^ ([@bib4]), *Tg(gata1a:DsRed)* ([@bib78]), *Tg(ptprc/CD45:DsRed)*^*sd3*^ ([@bib5]), *Tg(--3.5ubb:loxP-EGFP-loxP-mCherry)* \[*Tg(ubi:Switch)*\] ([@bib51]) and *Tg(ubb:loxPAmCyanSTOPloxPZsYellow)* \[*Tg(ubi:CSY)*\] ([@bib92]). *Tg(tcf21:DsRed2; myl7:eGFP)* and *Tg(kdrl:GFP; gata1a:DsRed)* double transgenic lines were generated by natural mating.

Method Details {#sec4.4}
--------------

### Generation of Transgenic Zebrafish Lines {#sec4.4.1}

To generate TgBAC(tcf21:myr-tdTomato)^ox181^, TgBAC(tcf21:H2B-Dendra2)^ox182^, TgBAC(tcf21:myr-eGFP)^ox183^, TgBAC(tbx18:myr-eGFP)^ox184^, TgBAC(tbx18:myr-Citrine)^ox185^, TgBAC(wt1b:H2B-Dendra2)^ox186^ and TgBAC(wt1b:Cre-2A-mCherry)^ox142^ we used a BAC recombineering approach ([@bib9]). Dendra2, tdTomato, eGFP and Citrine fluorophore sequences were linked to 5' histone 2b (H2B) or 2x myristoylation (myr) sequences ([@bib18], [@bib89]). pGEM H2B-Dendra2-FRT-Kan-FRT, pGEM myr-tdTomato-FRT-Kan-FRT, pGEM myr-eGFP-FRT-Kan-FRT, pGEM myr-Citrine-FRT-Kan-FRT and pGEM Cre-2A-mCherry-FRT-Kan-FRT recombination donor constructs were generated by amplifying H2B-Dendra2, myr-tdTomato, myr-eGFP, myr-Citrine and Cre-2A-mCherry cassettes using Herculase II fusion DNA polymerase (Agilent Technologies) and cloning them into the donor plasmid (\#89890, Addgene) using InFusion (InFusion HD Cloning kit, Clontech). BACs used were DKEYP 79F12 (tcf21), DKEYP 117G5 (tbx18) and CH73 157N22 (wt1b). Donor constructs were inserted into the first coding exon of tcf21, tbx18 or wt1b BACs via bacterial homologous recombination as previously described ([@bib79]). Primers used are listed in [Table S1](#mmc1){ref-type="supplementary-material"}. The corresponding constructs used for amplification of donor fragments flanked with recombinant arms are available from Addgene (\#119864 - \#119868). BACs were injected into one-cell zygotes and integrated into the genome via Tol2-mediated recombination. TgBAC(tcf21:myr-tdTomato;tbx18:myr-eGFP;wt1b:H2B-Dendra2)^ox187^ was generated by two consecutive rounds of breeding from TgBAC(tcf21:myr-tdTomato)^ox181^, TgBAC(wt1b:H2B-Dendra2)^ox186^ and TgBAC(tbx18:myr-eGFP)^ox184^. Images of euthanised larvae were obtained using a LSM780 confocal microscope (ZEISS) and a 20x objective.

### Larval Heart Isolation, Dissociation and FAC-Sorting {#sec4.4.2}

Larvae were euthanised using tricaine methanesulfonate (MS-222) and larval hearts were isolated following a published protocol ([@bib8]), using a 21-gauge needle for disruption. This procedure recovered around 50% of the larval hearts. Hearts were dissociated using 15mg/ml collagenase (C8176, Sigma Aldrich) in 0.05% trypsin solution at 30°C for 14mins. Single cells were sorted on a BD FACS-Aria Fusion into Smart-seq2 lysis buffer dispensed in 96 well plates. 7-AAD cell viability dye was used to exclude non-viable cells during FACS. 288 fluorescent cells were purified from *TgBAC(tcf21:H2B-Dendra2)*^*ox182*^ (300 hearts), 96 fluorescent cells from *TgBAC(tbx18:myr-eGFP)*^*ox184*^ (180 hearts) and 96 fluorescent cells from *TgBAC(wt1b:H2B-Dendra2)*^*ox186*^ (130 hearts). Additionally, 31 GFP positive cells were collected from *Tg(myl7:eGFP)*^*f1*^ (40 hearts), 40 GFP positive cells and 20 DsRed fluorescent cells from *Tg(kdrl:GFP; gata1a:DsRed)* (65 hearts), 96 non-fluorescent cells from *Tg(tcf21:DsRed2; myl7:eGFP)* x *Tg(kdrl:GFP; gata1a:DsRed)* (100 ventricles) and 96 cells from 50 wildtype hearts. Cells from *TgBAC(tcf21:H2B-Dendra2)*^*ox182*^ were sorted in four separate FACS sessions, GFP positive and DsRed positive cells from *Tg(kdrl:GFP; gata1a:DsRed)* and GFP positive cells from *Tg(myl7:eGFP)*^*f1*^ were sorted in one session, cells in all other conditions were sorted separately in one session each. Cells sorted in separate FACS sessions were processed separately during cDNA synthesis, cells sorted in one session were processed as one batch. Three empty wells were processed within the *kdrl*:GFP, *gata1a*:DsRed batch. During library preparation and sequencing, cDNA samples from *tbx18*:myr-eGFP, *wt1b*:H2B-Dendra2, *kdrl*:GFP, *gata1a*:DsRed and *myl7*:eGFP conditions were scrambled and processed as two new batches, *tcf21*:H2B-Dendra2,*myl7*:eGFP,*kdrl*:GFP,*gata1a*:DsRed quadruple negative and wildtype conditions were processed in one batch, all other conditions were processed separately.

During *sema3fb* knockout experiments, 241 Citrine positive single cells were purified from 300 *TgBAC(tbx18:myr-Citrine)*^*ox185*^ hearts in three batches and sorted into 96-well plates containing lysis buffer with protease (Qiagen). cDNA was synthesised separately for each batch. Batches were combined during library preparation and sequencing.

### Single Cell Library Preparation and Sequencing {#sec4.4.3}

Single cells were processed following the Smart-seq2 protocol ([@bib63]) to reverse transcribe poly-adenylated RNA. cDNA was then amplified with 20 PCR cycles. In two of the batches of cells sorted from *TgBAC(tcf21:H2B-Dendra2)*^*ox182*^, all cDNA samples were taken further into library preparation and sequencing. However, only a low percentage of these samples passed the quality control after sequencing ([Figure S2](#mmc1){ref-type="supplementary-material"}F). Therefore, in all other batches the amount of synthesized cDNA was quantified using the Quant-iT PicoGreen dsDNA Assay (ThermoFisher). cDNA quality of 11 samples sampling the whole range of the obtained PicoGreen results was tested on an Agilent 2100 Bioanalyzer (Agilent Technologies). The Bioanalyzer results were used to determine a quality cut-off PicoGreen value. Only cDNA samples with a PicoGreen value above the cut-off were taken further into library preparation. Final sequencing libraries were prepared using the Nextera XT DNA Library Preparation Kit (FC-131-1024, Illumina) and 75bp paired-end sequencing reads were generated on a NextSeq500 platform (Illumina). The number of sequenced cells for each condition can be found in [Figure S2](#mmc1){ref-type="supplementary-material"}.

### KO *sema3fb* Single Cell Library Preparation and Sequencing {#sec4.4.4}

Single cells isolated from hearts of euthanised 5dpf *sema3fb* knockout larvae were processed adapting the TARGET-seq protocol ([@bib68]). Similar to TARGET-seq, single cells were subjected to a mild protease digestion to release genomic DNA. In addition to template-switching and oligo-dT primers, primers specific to *sema3fb* mRNA were used to enforce reverse transcription of *sema3fb* during first-strand synthesis. Primers specific for *sema3fb* cDNA were added during cDNA amplification. Additionally, genomic DNA primers binding intronic sequences surrounding the target sites of *sema3fb* sgRNA1 (exon 2) and sgRNA4 (exon 10) were added into the same PCR mix. Single cell cDNA was amplified using 24 PCR cycles. Primer specificity was validated against zebrafish RefSeq mRNA and genomic DNA assemblies in PrimerBlast. Final sequencing libraries were prepared using the Nextera XT DNA Library Preparation Kit (Illumina) and 130 libraries were sequenced on a NextSeq500 platform (Illumina), generating 75bp paired-end sequencing reads. A subset of 40 samples was re-sequenced for increased coverage of the *sema3fb* locus, generating 75bp single-read sequencing reads. Primer sequences can be found in [Table S4](#mmc1){ref-type="supplementary-material"}.

### KO *cxcl12a* Single Embryo Library Preparation and Sequencing {#sec4.4.5}

Zygotes were injected with two sgRNAs targeting AmCyan (control, n=3) or sgRNA1 and sgRNA3 targeting *cxcl12a* (KO *cxcl12a*, n=6), single larvae were euthanised using MS-222 shortly before 5dpf and RNA was extracted using the RNaqueous Micro Kit (Ambion). Approximately 50ng of purified RNA was processed with SMARTScribe reverse transcriptase (Clontech), using 1.5μM *cxcl12a* specific exonic reverse primer and 5μM Smart-seq2 template-switching oligo. cDNA was amplified using SeqAmp polymerase (Clontech), 0.33 μM Smart-seq2 ISPCR primers and 6 PCR cycles. Final sequencing libraries were prepared using the Nextera XT DNA Library Preparation Kit (Illumina) and libraries were sequenced on a NextSeq500 platform (Illumina), generating 75bp paired-end sequencing reads. All samples were re-sequenced for increased coverage, generating 75bp single-read sequencing reads. The *cxcl12a* primer sequence can be found in [Table S4](#mmc1){ref-type="supplementary-material"}.

### Hybridisation Chain Reaction {#sec4.4.6}

Larvae were euthanised using MS-222 and fixed in 4% paraformaldehyde (PFA) overnight at 4°C. Subsequently, larvae were stored at -20°C in methanol. Hybridisation chain reaction (HCR) v3.0 ([@bib13]) was performed following a protocol by Choi et al. Briefly, larvae were permeabilized using 30μg/ml proteinase K for 45 minutes at room temperature, post-fixed in 4% PFA and incubated overnight at 37°C in 30% probe hybridisation buffer containing 2pmol of each probe mixture. Excess probes were washed off with 30% probe wash buffer at 37°C and 5xSSCT at room temperature and larvae were incubated overnight at room temperature in amplification buffer containing 15pmol of each fluorescently labelled hairpin. Following HCR, larvae were incubated with Hoechst reagent (1:1000, 5xSSCT) for 30 minutes at room temperature. Probe sequences were designed by the manufacturer. Probe sets used were: dr_tcf21-B1, dr_tbx18-B2, dr_wt1b-B3, dr_myl7-B5, dr_adma-B3, dr_jam2b-B4, dr_elnb-B4, dr_cldn11a-B2, dr_tgm2b-B4, dr_sema3fb-B5, dr_nrp1a-B4, dr_nrp2a-B3, dr_cxcl12a-B3, dr_cxcr4b-B5, dr_ptprc-B4, EGFP-B4, Dendra2-B5, tdTomato-B5, mCherry-B1. During BAC reporter line validation, HCR was performed using probes specifically targeting exon 1 of *tcf21*, *tbx18* or *wt1b* (dr_tcf21_exon1-B1, dr_tbx18_exon1-B2, dr_wt1b_exon1-B3), which was absent from the BAC reporter constructs. Images were obtained using a LSM780 confocal microscope (ZEISS) and a 40x objective. Contrast and brightness were adjusted separately for each colour channel.

### Immunocytochemistry {#sec4.4.7}

Larvae were euthanised using MS-222 and fixed in 4% PFA for 45 minutes at room temperature. After washing, larvae were blocked using 5% goat serum (PBS, 0.5% Triton, 2% DMSO) for 1 hour at room temperature. Primary antibodies used were: chicken anti-GFP (ab13970, abcam, 1:500), rabbit anti-DsRed (632496, Clontech, 1:500), mouse anti-Dendra2 (TA180094, clone OTI1G6, Origene, 1:500), mouse anti-Mlck (M7905, Sigma-Aldrich, 1:500) and rabbit anti-cxcr4b (GTX132244, Genetex, 1:300), added overnight at 4°C. Secondary antibodies and Hoechst reagent were used at 1:1000 dilution and added for 2 hours at room temperature. Images were obtained using a LSM780 confocal microscope (ZEISS) and a 40x objective, or a MVX10 fluorescence stereo microscope (Olympus). Contrast and brightness were adjusted separately for each colour channel.

### EdU Staining {#sec4.4.8}

Larvae were incubated in embryo medium containing 1mM EdU and 1% DMSO. During *sema3fb* knockout experiments, larvae were incubated for 18 hours, from 102hpf to shortly before 120hpf. During *tgm2b* knockout experiments, larvae were incubated for 11 hours, from 66hpf until 77hpf. KO *sema3fb* larvae were stained by immunocytochemistry against GFP, followed by detection of EdU using the Click-iT Alexa Fluor 647nm kit (ThermoFisher) for 2 hours at room temperature. KO *tgm2b* larvae were immuno-stained against Dendra2, followed by EdU detection.

### Lineage Tracing {#sec4.4.9}

4-hydroxytamoxifen (4-OHT) was added to the embryo medium at a final concentration of 10μM, from a 1mM stock solution made in 100% ethanol. Embryos were incubated with 4-OHT from 10 hours-post-fertilisation (hpf) or 43hpf. For embryos incubated with 4-OHT from 10hpf, the 4-OHT containing medium was renewed at 2dpf and at 4dpf. For embryos incubated from 43hpf, the 4-OHT containing medium was replaced at 4dpf. Embryos were grown until shortly before 5dpf.

### Transient Cas9-Mediated Gene Knockout {#sec4.4.10}

sgRNAs against the coding region of the target gene were designed to have a high Cas9-mediated nuclease cutting efficiency, a low number of genomic off-target sites and a target site proximal to the recognition site of a restriction enzyme. sgRNA primers (see [Table S2](#mmc1){ref-type="supplementary-material"}) were annealed and the product inserted via Golden Gate cloning into a U6a mini-vector containing a tracrRNA backbone and Ds transposon sequences (Addgene \#119069). sgRNA vectors were first injected individually to test their Cas9-mediated nuclease cutting efficiency. Typically, 30pg of vector was injected into one-cell stage zygotes, together with 10pg Ac mRNA and 160pg Cas9 mRNA. For actual gene editing experiments, two sgRNA vectors were co-injected at an amount of 30-38pg each. Control embryos were injected with two sgRNA vectors targeting mCherry (KO *tgm2b*, *sema3fb*) or AmCyan (KO *cxcl12a*).

### Cas9 Activity Efficiency Test {#sec4.4.11}

One cell stage zygotes were injected with a single sgRNA vector, Ac mRNA and Cas9 mRNA. Genomic DNA from single euthanised embryos was isolated at 1dpf and the genomic region surrounding the sgRNA target site (200-400bp) was amplified via PCR (see [Table S3](#mmc1){ref-type="supplementary-material"} for primers used). Half the volume of each PCR product was digested with a restriction enzyme that had a recognition site overlapping or adjacent to the sgRNA target site.

### Generation of Stable Mutant Zebrafish Lines {#sec4.4.12}

We injected *tgm2b* sgRNA2 vector, Ac mRNA and Cas9 mRNA into one cell stage *TgBAC(tcf21:H2B-Dendra2)*^*ox182*^ x *TgBAC(tbx18:myr-Citrine)*^*ox185*^ zygotes, reared fluorescent fish to adulthood and screened for germline transmission of editing events to generate *tgm2b*^*38ins/38ins*^ *mutant in the Tg(tcf21:H2B-Dendra2;tbx18:myr-Citrine)* background (ox188) and *tgm2b*^*7del1sub/7del1sub*^ *mutant in Tg(tcf21:H2B-Dendra2;tbx18:myr-Citrine)* background (ox189). Similarly, we injected *cxcl12a* sgRNA1 vector into *Tg(ptprc/CD45:DsRed)*^*sd3*^ x *TgBAC(tcf21:myr-eGFP)*^*ox183*^ zygotes to generate *cxcl12a*^*15del/15del*^ in *Tg(ptprc/CD45:DsRed; tcf21:myr-eGFP)* background (ox190). To identify mutants, embryos were fin-clipped and extracted genomic DNA was PCR amplified using the primers:

*tgm2b*\_sgRNA2_for GGGAGGAAGCGTTCAGATACTA and

*tgm2b*\_sgRNA2_rev ATACCGCACTGGCAGACAC (wildtype PCR product size 61bp), or *cxcl12a*\_sgRNA1_for GCAAACATGGATCTCAAAGTGA and

*cxcl12a*\_sgRNA1_rev TTAACTTACCGTTGGAAATCGG (wildtype PCR product size 82bp). The sizes of the PCR products were then determined using gel electrophoresis. Mutant genotypes were characterised via Sanger sequencing.

### Bioinformatic Processing {#sec4.4.13}

#### Single Cell RNA Sequencing Data Analysis {#sec4.4.13.1}

Transcriptomic data was mapped to the zebrafish reference genome (GRCz10-91) using the STAR gapped aligner ([@bib20]). Duplicate reads were removed and reads were summarized using featureCounts ([@bib41]). FeatureCounts files containing data from different sequencing batches were subsequently concatenated. Quality control of the single cell read counts was done using the Scater R package ([@bib46]). Libraries that had a size more than 3 median absolute deviations (MADs) below the median of the whole dataset were excluded from the analysis. Furthermore, libraries were excluded from the analysis if the number of expressed genes was more than 3 MADs below the median of the whole dataset, or if the percentage of counts representing ERCC spike-in features was more than 3 MADs above the median of the whole dataset. Genes with an average expression across all cells of below 0.1 counts as well as mitochondrial genes were excluded from analysis. Quality control plots can be found in [Figure S2](#mmc1){ref-type="supplementary-material"}. The cleaned dataset was further processed using Pagoda routines in the scde package ([@bib22], [@bib33]). Genes annotated to cell cycle related gene ontology terms were excluded from the dataset. Gene enrichment in the single cell clusters was analysed with scde. Counts were transformed into FPKM expression values with the rpkm() command in the edgeR package ([@bib67]) and heatmaps drawn using pheatmap. The Rtsne package ([@bib36]) was used to plot t-SNE representations of the dataset that were based on 2376 highly variable genes. Gene ontology term analysis was performed with the R topGO package ([@bib2]), using enriched genes with cZ\>2. RNA velocity was analysed using the Velocyto R package ([@bib38]) and pseudotime analysis was performed using the Monocle 2 package ([@bib65]).

#### KO *sema3fb* Single Cell RNA Sequencing Data Analysis {#sec4.4.13.2}

To identify single cell clusters, sequencing data from *sema3fb* knockout samples was processed using the Pagoda pipeline as described above. FPKM values were computed using the rpkm() function in edgeR. Raw counts for *sema3fb* were generated using featureCounts and a custom gene annotation in which exons targeted by *sema3fb* sgRNAs and amplified from genomic DNA (exons 2 and 10) were absent. Raw counts were then normalised to sample library size; no *sema3fb* FPKM values were determined since effective *sema3fb* transcript lengths could not reliably be computed for each single cell sample. To analyse genome editing, STAR mapped sequencing reads (without duplicates) were inspected using the Integrative Genomics Viewer ([@bib66]). For re-sequenced samples, the two BAM files were merged using samtools ([@bib40]). 14 samples containing reads covering at least one of the sgRNA target sites (sgRNA1: chr11:35307703, sgRNA4:chr11:35213000) were analysed in further detail. For these samples, sequences of reads spanning the sgRNA target sites were compared to the genomic reference sequence and to reads of wildtype *sema3fb* positive cells from the original scRNASeq dataset. Samples with read sequences that differed from these reference sequences were classified as genome-edited. Editing types detected were grouped into insertions/deletions (indels), basepair substitutions and large deletions over 10kb in length. The effect of genome editing on the sema3fb protein open reading frame (ORF) was analysed using SnapGene Viewer (SnapGene) and the lengths of edited sema3fb ORFs were normalised to wildtype sema3fb length (791aa). IGV was used to generate Sashimi plots showing splicing of *sema3fb*. In 9 samples that contained spliced reads for more than one *sema3fb* splice junction, the number of reads indicating aberrant *sema3fb* splicing was normalised against the total number of *sema3fb* splicing reads and plotted. 12 non *sema3fb* knockout *sema3fb* expressing single cell transcriptome samples were analysed similarly.

#### KO *cxcl12a* RNA Sequencing Data Analysis {#sec4.4.13.3}

Sequencing reads were mapped with STAR to GRCz10-91, duplicate reads removed and the *cxcl12a* locus analysed using IGV. Read sequences at the sgRNA target sites (chr13:30674045 sgRNA1, chr13:30676177 sgRNA3) were compared to the reference genome. The numbers of reads that contained indels or substitutions or that indicated aberrant splicing from exon 1 to exon 3 were normalised against the total number of reads spanning the respective sgRNA target site. Sashimi plots were generated with IGV and the number of reads that indicated aberrant splicing from exon 1 to exon 3 was normalised against the total number of reads splicing from exon 1. The cxcl12a ORFs resulting from genome editing were analysed in SnapGene Viewer and their lengths were normalised against the wildtype cxcl12a length (99aa). FPKM values were computed manually. To determine the effective transcript length (as produced by Smart-seq2 template-switching oligo and *cxcl12a* cDNA reverse primer) for each sample, the amount of *cxcl12a* transcripts not containing exon 2 (length 1224bp) was weighted against the amount of wildtype transcript (length 1342bp) using the previously computed ratio of aberrant splicing.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Statistical details of experiments can be found in the figures, figure legends and main text, including p-values and numbers of animals analysed. Statistical analyses were performed in R. Plots were generated with ggplot2 ([@bib84]) in R. For the scRNA-seq GO-term enrichment analysis, significance was calculated using Fisher\'s exact test with Bonferroni correction for multiple testing. For data shown in [Figures 4](#fig4){ref-type="fig"}--[6](#fig6){ref-type="fig"}, significance was calculated using Welch's t-test. Some plots include box and whiskers plots (in the style of Tukey), indicating median and first/third quartiles.

Data and Code Availability {#sec4.6}
--------------------------

Raw and processed sequencing data generated in this study was submitted to GEO (accession number [GSE121750](ncbi-geo:GSE121750){#intref0135}).
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